News

The Expanding Value Footprint of Oncology Drugs

The Expanding Value Footprint of Oncology Treatments

13 May 2014

A new OHE Consulting Report examines the importance and history of HTA evaluations for additional uses for cancer drugs after their initial approval. The potential value…

Cracks through the ice on a melting glacier in Alaska

2014 Annual Lecture: Is Universal Health Care Coverage the Holy Grail?

7 May 2014

Join us on the evening of 9 June 2014 when OHE will welcome Professor Anne Mills of the London School of Hygiene and Tropical Medicine who…

Cracks through the ice on a melting glacier in Alaska

Innovation in Oncology: Real Option Value and Path Dependence

29 April 2014

Real Option Value and Path Dependence in Oncology Innovation. Based on an OHE Lunchtime Seminar, this Seminar Briefing addresses a persistent issue: how to adequately reward…

Cracks through the ice on a melting glacier in Alaska

How Will Demands for Effectiveness Evidence Change Drug Development?

23 April 2014

Interviews with 19 senior pharma execs suggest how and to what extent effectiveness research may be integrated into drug development. Changes in the clinical and economic…

Cracks through the ice on a melting glacier in Alaska

Biosimilars and HTA: Results of a Roundtable Discussion

9 April 2014

Experts from the three UK HTA agencies, the MHRA, and academia discussed which HTA methods are most appropriate for biosimilars in specific situations. OHE convened a…

Cracks through the ice on a melting glacier in Alaska

Use of Cost-effectiveness Evidence in US Health Care: Seminar Briefing

1 April 2014

Just published by OHE, this Seminar Briefing summarises remarks at an OHE Lunchtime Seminar by Dr James Chambers of the Center for the Evaluation of Value…

Cracks through the ice on a melting glacier in Alaska

OHE Models Incentives for Antibiotic Drug Development

18 March 2014

The OHE model takes into account the value to society of new antibiotics as well as the risks and rewards for payers and the entities developing…

Researchers

Defining the Complementarity of Medical Research Across Sectors in the UK

11 March 2014

Under an MRC grant, OHE is collaborating to estimate in monetary terms the synergies of medical research spending in the UK by the pharma industry, charities…

Cracks through the ice on a melting glacier in Alaska

Using Performance Thresholds to Affect GP Behaviour: Evidence from Scotland

4 March 2014

Whether and how a change in performance-related payment motivated change in GP behaviour in Scotland is investigated in a recent article by OHE’s Yan Feng and…